Skip to main content

Advertisement

Log in

Inclusion complexes of 5-flucytosine with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: characterization in aqueous solution and in solid state

  • Original Article
  • Published:
Journal of Inclusion Phenomena and Macrocyclic Chemistry Aims and scope Submit manuscript

Abstract

Complexation between 5-flucytosine (5-FC), a cytosine analogue with in vitro antifungal and antiyeast activity, and β-cyclodextrins (β-cyclodextrin and hydroxypropyl-β-cyclodextrin) was studied in solution and in solid states. Complexation in solution was evaluated using solubility studies, UV–vis and 1H-NMR. In the solid state, differential scanning calorimetry (DSC), scanning electron microscopy (SEM), FT-IR and X-ray diffraction studies were used. UV–vis, FT-IR and 1H-NMR spectroscopy studies showed that the complex formed occurs by complexation of piridinique base analogue into inner cavity. DSC studies showed the existence of a complex of 5-FC with β-CDs. X-ray studies confirmed the DSC results of the complex existence. Solubility studies showed that the complexed drug is forty times more soluble than free 5-FC, indicating the obtained systems as future, promising drug carriers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. Vermes, A., Guchelaar, A.J., Dankert, J.: Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J. Antimicrob. Chemother. 46, 171–179 (2000)

    Article  CAS  Google Scholar 

  2. Hedges, A.R.: Industrial applications of cyclodextrins. Chem. Rev. 98, 2035–2044 (1998)

    Article  CAS  Google Scholar 

  3. Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017–1025 (1996)

    Article  CAS  Google Scholar 

  4. Spulber, M., Pinteala, M., Harabagiu, V., Simionescu, B.C. Inclusion complexes of Sulconazole with β-cyclodextrin and hydroxypropyl β-cyclodextrin: characterization in aqueous solution and in solid state. J. Incl. Phenom. Macro. doi:10.1007/s10847-007-9391-3

  5. Scholer, H.J.: Flucytosine. In: Speller, D.C.E. (ed.) Antifungal Chemotherapy, pp. 35–106. Wiley & Sons, Chichester (1977)

    Google Scholar 

  6. Francis, P., Walsh, T.J.: Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy. Clin. Infect. Dis. 15, 1003–1018 (1992)

    CAS  Google Scholar 

  7. Viviani, M.A.: Flucytosine-what is its future? J. Antimicrob. Chemother. 35, 241–244 (1995)

    Article  CAS  Google Scholar 

  8. Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instr. 4, 117–212 (1965)

    CAS  Google Scholar 

  9. Manca, M.L., Zaru, M., Ennas, G., Valenti, D., Sinico, C., Loy, G., Fadda, A.M.: Diclofenac-β-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies. AAPS PharmSciTech. 6(3), 464–472 (2005)

    Article  Google Scholar 

  10. Chala, R., Ahuja, A., Ali, J., Khar, R.K.: Cyclodextrins in drug delivery: un updated review. AAPS PharmSciTech. 6(2), 329–357 (2005)

    Article  Google Scholar 

  11. Mukne, A.P., Nagarsenker, M.S.: Triamterene-β-cyclodextrin systems: preparation, characterization and in vivo evaluation. AAPS PharmSciTech. 5(1), 83–90 (2004)

    Article  Google Scholar 

  12. Piel, G., Dive, G., Ervard, B., Van Hees, T., Henry de Hassonville, S., Delattre, L.: Molecular modeling study of β- and γ-cyclodextrin complexes with miconazole. Eur. J. Pharm. Sci. 13, 271–279 (2001)

    Article  CAS  Google Scholar 

  13. Wang, P., Jeng, R.: Separation of purine and pyrimidine bases by capillary electrophoresis using β-cyclodextrin as an additive. J. Pharm. Biomed. Anal. 9(6), 277–283 (2004)

    Article  Google Scholar 

  14. Vrkic, A., O’Hair, R.A.J.: Unusual covalent bond-breaking reactions of β-cyclodextrin inclusion complexes of nucleobases/nucleosides and related guest molecules. Eur. J. Mass. Spectrom. 9(6), 563–577 (2003)

    Article  CAS  Google Scholar 

  15. Figueiras, A., Ribeiro, L., Vieira, M.T., Veiga, E.F.: Preparation and physicochemical characterization of omeprazole: methyl-beta-cyclodextrin inclusion complex in solid state. J Incl Phenom Macrocycl Chem. 57, 173–177 (2007)

    Article  CAS  Google Scholar 

  16. Moyano, J.R., Gine′ s, J.M., Arias, M.J., Rabasco, A.M.: Study of the dissolution characteristics of oxazepam via complexation with β-cyclodextrin. Int. J. Pharm. 114, 95–102 (1995)

    Article  CAS  Google Scholar 

Download references

Acknowledgment

This research was financial supported by Grant 2 CEex D11-106/2006 (CICLOMED).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mariana Spulber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spulber, M., Pinteala, M., Fifere, A. et al. Inclusion complexes of 5-flucytosine with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: characterization in aqueous solution and in solid state. J Incl Phenom Macrocycl Chem 62, 117–125 (2008). https://doi.org/10.1007/s10847-008-9446-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10847-008-9446-0

Keywords

Navigation